Zobrazeno 1 - 5
of 5
pro vyhledávání: '"Aditi P. Singh"'
Autor:
Erica L. Carpenter, Roger B. Cohen, Corey J. Langer, Joshua M. Bauml, Jeffrey S. Wasser, Aditi P. Singh, Christine A. Ciunci, Abigail T. Berman, Elena Helman, Rebecca J. Nagy, Kimberly C. Banks, Benjamin A. Silva, Michael J. LaRiviere, Theresa E. Christensen, Stephanie S. Yee, Taylor A. Black, Wei-Ting Hwang, Katie J. Quinn, Austin L. Chien, Jeffrey C. Thompson, Charu Aggarwal
Mutations Analyzed
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::08350c21e7795ce9c29cff93a63f6bbf
https://doi.org/10.1158/1078-0432.22475610
https://doi.org/10.1158/1078-0432.22475610
Autor:
Erica L. Carpenter, Roger B. Cohen, Corey J. Langer, Joshua M. Bauml, Jeffrey S. Wasser, Aditi P. Singh, Christine A. Ciunci, Abigail T. Berman, Elena Helman, Rebecca J. Nagy, Kimberly C. Banks, Benjamin A. Silva, Michael J. LaRiviere, Theresa E. Christensen, Stephanie S. Yee, Taylor A. Black, Wei-Ting Hwang, Katie J. Quinn, Austin L. Chien, Jeffrey C. Thompson, Charu Aggarwal
Purpose:The role of plasma-based tumor mutation burden (pTMB) in predicting response to pembrolizumab-based first-line standard-of-care therapy for metastatic non–small cell lung cancer (mNSCLC) has not been explored.Experimental Design:A 500-gene
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::5dfee398bbbbfc5c85644bb8ae085830
https://doi.org/10.1158/1078-0432.c.6529125
https://doi.org/10.1158/1078-0432.c.6529125
Autor:
Erica L. Carpenter, Roger B. Cohen, Corey J. Langer, Joshua M. Bauml, Jeffrey S. Wasser, Aditi P. Singh, Christine A. Ciunci, Abigail T. Berman, Elena Helman, Rebecca J. Nagy, Kimberly C. Banks, Benjamin A. Silva, Michael J. LaRiviere, Theresa E. Christensen, Stephanie S. Yee, Taylor A. Black, Wei-Ting Hwang, Katie J. Quinn, Austin L. Chien, Jeffrey C. Thompson, Charu Aggarwal
pTMBand PD-L1 expression levels.
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::907404d8eb997d205afbd17afc601de9
https://doi.org/10.1158/1078-0432.22475613.v1
https://doi.org/10.1158/1078-0432.22475613.v1
Autor:
Erica L. Carpenter, Roger B. Cohen, Corey J. Langer, Joshua M. Bauml, Jeffrey S. Wasser, Aditi P. Singh, Christine A. Ciunci, Abigail T. Berman, Elena Helman, Rebecca J. Nagy, Kimberly C. Banks, Benjamin A. Silva, Michael J. LaRiviere, Theresa E. Christensen, Stephanie S. Yee, Taylor A. Black, Wei-Ting Hwang, Katie J. Quinn, Austin L. Chien, Jeffrey C. Thompson, Charu Aggarwal
Development and validation of a plasma-based panel for mutation detection and assessment of TMB.
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::ab8830cf164cccd5b1739f881aa15920
https://doi.org/10.1158/1078-0432.22475619.v1
https://doi.org/10.1158/1078-0432.22475619.v1
Autor:
Aditi P. Singh, Ni Fan, Feng Wang, Roman Perez-Soler, Huijie Liu, Alain Borczu, Haiying Cheng, Balazs Halmos
Publikováno v:
Cancer Research. 78:905-905
Background: Despite treatment advances, most lung cancer patient will still receive platinum-based chemotherapy and platinum resistance remains a serious clinical problem. RICTOR is a key component of the mTOR complex 2. Activation of RICTOR signalin